Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 71 Neoplasms 70 Lung Neoplasms 29 Prostatic Neoplasms 26 Head and Neck Neoplasms 22 Colorectal Neoplasms 19 Uterine Cervical Neoplasms 17 Ovarian Neoplasms 13 Neoplasm Metastasis 13 Motor Activity 13 Fatigue 11 Endometrial Neoplasms 11 Colonic Neoplasms 11 Brain Neoplasms 11 Pain 10 Carcinoma, Non-Small-Cell Lung 10 Multiple Myeloma 9 Melanoma 9 Rectal Neoplasms 8 Leukemia 8 Gastrointestinal Neoplasms 8 Smoking Cessation 7 Pancreatic Neoplasms 7 Lymphoma 7 Depression 7 cyclopia sequence 6 Esophageal Neoplasms 6 Carcinoma, Renal Cell 6 Advanced Cancer 6 Uterine Neoplasms 5

Interventions

senaparib 7 pembrolizumab 7 Irinotecan 6 Paclitaxel 5 Docetaxel 5 Cisplatin 5 Capecitabine 5 Nivolumab 4 Fluorouracil 4 Bevacizumab 4 Rifampin 3 Midazolam 3 Leucovorin 3 Itraconazole 3 Injections 3 pertuzumab 2 ontuxizumab 2 navoximod 2 atezolizumab 2 Gemcitabine 2 vofatamab 1 tremelimumab 1 trastuzumab duocarmazine 1 talazoparib 1 sotorasib 1 sintilimab 1 saracatinib 1 rucaparib 1 ridaforolimus 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumor × Surveys and Questionnaires × Clear all

NCT05359718 2024-11-14

PICO SM

The Christie NHS Foundation Trust

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡